New Study Reveals Potential Treatment for Neurological Lyme Disease
April 18, 2024 11:00 ET
|
Bay Area Lyme Foundation
PORTOLA VALLEY, Calif., April 18, 2024 (GLOBE NEWSWIRE) -- Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the US, recently announced publication of a laboratory study...
OPTIZMO™ Releases 2023 Email Opt-Out Infographic
April 18, 2024 09:00 ET
|
OPTIZMO Technologies, LLC
The infographic presents unique insights and data from hundreds of millions of opt-out requests, focusing on timing, geographic location, and device usage.
Renewables and nascent low-carbon technologies most exposed to high interest rates
April 18, 2024 06:25 ET
|
Wood Mackenzie
NEWS RELEASE Renewables and nascent low-carbon technologies most exposed to high interest rates Policymakers should...
atai Life Sciences Announces the Publication of Beckley Psytech’s Phase 1 Study of BPL-003 in the Journal of Psychopharmacology
April 17, 2024 07:00 ET
|
atai Life Sciences
BPL-003 is Beckley Psytech’s novel patent-protected benzoate salt formulation of 5-MeO-DMT that is administered intranasally.BPL-003 was shown to be safe and well-tolerated with a predictable...
[Latest] Global Lung Tumor Market Size/Share Worth USD 46.3 Billion by 2033 at a 7.7% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
April 15, 2024 12:30 ET
|
Custom Market Insights
Austin, TX, USA, April 15, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Lung Tumor Market Size, Trends and Insights By Product (Imaging systems, Biopsy...
London Research & Pharmaceuticals presents the advancement of LRP-661, their oral cannabidiol sulphate drug candidate at the prestigious Epilepsy Therapies & Diagnostics Development (ETDD) XVII conference in Miami
April 15, 2024 08:00 ET
|
London Research and Pharmaceuticals
London Research & Pharmaceuticals Corp. Presents the Advancement of their Oral Cannabidiol Sulphate Drug Candidate at Epilepsy Therapies Conference
Nokia and SURF reach 800Gb/s transmission on existing fiber to prepare for massive upgrade to CERN's Large Hadron Collider
April 15, 2024 07:30 ET
|
Nokia Oyj
Press ReleaseNokia and SURF reach 800Gb/s transmission on existing fiber to prepare for massive upgrade to CERN's Large Hadron Collider Trial conducted over 1648 km existing fiber link connecting...
InterDigital and Concordia University Announce Research Collaboration on AI-enabled Immersive Media Delivery over 5G Networks
April 15, 2024 04:00 ET
|
InterDigital, Inc.
WILMINGTON, Del., April 15, 2024 (GLOBE NEWSWIRE) -- InterDigital, Inc. (Nasdaq: IDCC), a mobile, video and AI technology research and development company, and Concordia University’s Intelligent...
Pixalate Releases March 2024 Rankings for Open Programmatic Ad Sellers on Made-For-Advertising (MFA) Websites: 18% of Global Ad Spend on MFA Sites Was Sold by Magnite
April 12, 2024 13:10 ET
|
Pixalate Inc.
LONDON, April 12, 2024 (GLOBE NEWSWIRE) -- Pixalate, the market-leading fraud protection, privacy, and compliance analytics platform for Connected TV (CTV) and Mobile Advertising, today released the...
AAMI Announces Ralph Basile Appointed to Philanthropic Activities for the AAMI Foundation
April 10, 2024 07:00 ET
|
AAMI
Arlington, Virginia, April 10, 2024 (GLOBE NEWSWIRE) -- AAMI is pleased to announce that Ralph Basile, standards corporate executive at Healthmark, will be stepping into a new philanthropic role...